The Chief Sanitary Inspector halts nationwide marketing of the medicinal product named Benlek, Metamizolum natricum monohydricum + Thiamini hydrochloridum + Coffeinum, tablets, 500 mg + 38.75 mg + 50 mg, pack of 20 tablets, GTIN 05909991492977
The responsible entity is SOLINEA sp. z o.o. sp. k. based in Ciecierzyn.
The decision was given the order of immediate enforceability.
Pursuant to Article 119a (2) of the A.P.F., the Chief Pharmaceutical Inspector shall, by decision, order the transfer of a medicinal product that was first marketed in the territory of the...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].